Cassava Sciences | PTIE - Market Capitalization

Stock Price
1.92
Daily Change
-0.05 -2.54%
Monthly
-8.57%
Yearly
-21.31%
Q1 Forecast
1.93

Cassava Sciences reported $85.2M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Amgen USD 184.41B 32.48B Feb/2026
Biogen USD 20.54B 2.13B Sep/2025
Cassava Sciences USD 86M 55M Feb/2026
Eisai JPY 1.45T 280.95B Sep/2025
Eli Lilly USD 1.02T 300.22B Feb/2026
Geron USD 874M 24M Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Merck USD 293.38B 83.74B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025